IEX Add to watchlist $210.83 +0.80 (+0.38%) Last updated: May 31, 2026 03:52
52-Week Range
$210.83
$157.25 $210.83 $223.85

Fundamentals Overview

IDEX Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 30.9 PEG 5.18 P/B 3.87 P/S 4.42

Intrinsic value (DCF)

+1.6% upside vs price

Profitability

Net margin 14.4%

Risk (Beta)

1.01 — in line vol

Earnings & growth

EPS $6.82 Rev -1.4% Profit -6.5% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 56% confidence Risk: Moderate Volatility — Beta 1.01. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (1 upgrade)

Pressures (Sell):

3M vs S&P 500: -6.9%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$15.60B
P/E (TTM)
30.9
EPS (TTM)
$6.82
Dividend Yield
1.36%
52-Week Range
$157.25 - $223.85
Volume vs Avg
N/A
Beta
1.01

About

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, ch...
Sector: Industrials
Headquarters: US
Employees: 9,000
IPO Date: Jun 1989
Beta: 1.01 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 18, Market Perform: 1, Neutral: 3, Outperform: 8.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $214.22; current price is $210.83. That’s a +1.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 30.9
DCF value (model) $214.22 (1.6% upside)
PEG (TTM) 5.18
P/B (TTM) 3.87
P/S (TTM) 4.42
P/FCF (TTM) 25.52
Liquidity & enterprise
Current Ratio (TTM) 3.39
Quick Ratio (TTM) 2.4
Cash Ratio (TTM) 1.16
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 14.38%
Gross margin (TTM) 44.42%
Operating margin (TTM) 20.8%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IEX.

Analyst Sentiment at a Glance

B+ Sentiment Improving
Buy 18Market Perform 1Neutral 3Outperform 8
1 upgrade, 0 downgrades
Price Target Consensus
Current $210.83
Median $250.00
Consensus $243.57
Low consensus $214.00
High consensus $257.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
TD Cowen maintain Buy Buy 2026-04-30
Citigroup maintain Buy Buy 2026-04-30
RBC Capital maintain Outperform Outperform 2026-04-30
Stifel maintain Buy Buy 2026-04-14
BMO Capital maintain Market Perform Market Perform 2026-03-27
Argus Research upgrade Hold Buy 2026-02-06
Citigroup maintain Buy Buy 2026-02-05
TD Cowen maintain Buy Buy 2026-02-05
DA Davidson maintain Neutral Neutral 2026-02-05
RBC Capital maintain Outperform Outperform 2026-02-05
Stifel maintain Buy Buy 2026-01-23
Citigroup maintain Buy Buy 2025-12-08
RBC Capital maintain Outperform Outperform 2025-10-30
Stifel maintain Buy Buy 2025-10-20
Oppenheimer maintain Outperform Outperform 2025-10-07
DA Davidson maintain Neutral Neutral 2025-08-04
RBC Capital maintain Outperform Outperform 2025-07-31
Oppenheimer maintain Outperform Outperform 2025-07-31
Stifel maintain Buy Buy 2025-07-31
Stifel maintain Buy Buy 2025-07-21
Citigroup maintain Buy Buy 2025-07-14
RBC Capital maintain Outperform Outperform 2025-05-02
Stifel maintain Buy Buy 2025-05-02
Stifel maintain Buy Buy 2025-04-14
Citigroup maintain Buy Buy 2025-04-14
DA Davidson maintain Neutral Neutral 2025-02-19
RBC Capital maintain Outperform Outperform 2025-02-06
Citigroup maintain Buy Buy 2025-01-13
Stifel maintain Buy Buy 2024-12-11
Citigroup maintain Buy Buy 2024-12-09